港股異動 | 合生創展(0754.HK)漲7%創12年半新高 持續回購股份
格隆匯9月30日丨合生創展集團(0754.HK)漲幅擴大至7%,報18.46港元,暫成交6136萬港元,最新總市值409億港元。公司股價自8月以來加速上漲,截至目前,累計漲幅已超80%,並創下2008年4月以來高。合生創展集團9月28日回購115.4萬股,涉資1999.11萬港元,月內累計回購股份13次,本年內至今為止(自普通決議案通過以來)累計購回證券數目為1675.8萬股。另外,公司8月份集團總合約銷售30.63億元,按年升約92.16%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.